±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 583  |  »Ø¸´: 6
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yelverxm

½ð³æ (СÓÐÃûÆø)

[½»Á÷] Çó½Ì¸ßάQSAR

¸Õ·¢ÏÖ¼ÆËã»úÄ£ÄâµÄ°å¿é£¬Ò©ÎïÉè¼Æ°æÃ澹ȻûÓÐÌù°¡¡£

ÎҾͷ¢¸öÎÊÌâÇë½Ìϸ÷λ¸ßÊÖ°É

±¾ÈË×î½üÕýÔÚѧϰ4DQSAR£¬µ«ÊÇÖ÷ÒªÏëÀûÓÃ4DµÄ¼¼Êõ×ö¸öQSPRÄ£ÐÍ£¬µ«²»ÖªµÀ²ÉÑùµÄÄÇЩ³ÌÐòÓÐÏֳɵĿÉÀûÓõÄÂð£¿

Èç¹ûÏÖ±àµÄ»°£¬±¾ÈË»¹ÊÇÓÐÒ»¶¨À§ÄѵĆª
»Ø¸´´ËÂ¥
In God we trust
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yalefield

½ð³æ (ÎÄ̳¾«Ó¢)

ÀϺºÒ»Ã¶

ºÇºÇ£¬5D QSAR¶¼ÒѾ­³öÀ´à¶

¡ï
zzgyb(½ð±Ò+1,VIP+0):ллÄãµÄ²ÎÓ룬ϣÍû¼ÌÐø¹Ø×¢¼ÆËãÄ£Äâ°æ
Sylvie Ducki, Grant Mackenzie, Nicholas J. Lawrence, and James P. Snyder
Quantitative Structure-Activity Relationship (5D-QSAR) Study of Combretastatin-like Analogues as Inhibitors of Tubulin Assembly
J. Med. Chem., 48 (2), 457-465, 2005.

Vedani A, Dobler M.
5D-QSAR: the key for simulating induced fit?
J Med Chem. 2002. 45(11):2139-2149

Vedani A, Dobler M, Dollinger H, Hasselbach KM, Birke F, Lill MA.
Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR.
J Med Chem. 2005. 48(5):1515-1527
5Â¥2007-12-10 22:11:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 7 ¸ö»Ø´ð

luai071

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сºì¶¹(½ð±Ò+1,VIP+0):¸Ðл·ÖÏí£¡ÐÁ¿àÁË£¡
¸ßάµÄQSARÎÒÈÏΪºÜ´ó³Ì¶ÈÉÏ»¹ÊǸÅÄîÐԵģ¬Ã»Óеõ½È«ÃæÈÏ¿ÉºÍÆÕ±éÓ¦Óã¬Èç¹ûÏëÕÒÒÑÓеÄËã·¨»ò³ÌÐòµÄ»°£¬¿ÉÒÔ´Ó²éÔÄÎÄÏ×ÈëÊÖ¡£
2Â¥2007-12-07 12:21:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yelverxm

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Originally posted by luai071 at 2007-12-7 12:21:
¸ßάµÄQSARÎÒÈÏΪºÜ´ó³Ì¶ÈÉÏ»¹ÊǸÅÄîÐԵģ¬Ã»Óеõ½È«ÃæÈÏ¿ÉºÍÆÕ±éÓ¦Óã¬Èç¹ûÏëÕÒÒÑÓеÄËã·¨»ò³ÌÐòµÄ»°£¬¿ÉÒÔ´Ó²éÔÄÎÄÏ×ÈëÊÖ¡£

ÎÒÒ²¾õµÃ¸ßάQSARûÓеõ½¹ã·ºÈÏͬ£¬ÏëHopfingerÌá³ö4DQSARÖ®ºó£¬·¢µÄ20¶àƪÎÄÕ¾ø´ó²¿·Ö»¹ÊÇËû×Ô¼ºÐ´µÄ¡­¡­

µ«ÊÇÎÒ¾õµÃÆä×÷ΪһÖÖ½â¾ö¹¹ÏóÃô¸ÐµÄ·½·¨£¬¿ÉÒÔÊÔÏ¡£

»¹µÃ¿´ÂÛÎÄȥѽ^^
In God we trust
3Â¥2007-12-08 02:11:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)

Êǰ¡£¬Ç°Ñض«Î÷Ò»¶¨µÃ¿¿×Ôѧ£¬ÍùÍù¡°È¨Íþ¡±Ò²²»¶®
4Â¥2007-12-10 14:22:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 290Çóµ÷¼Á085701 +9 1314Åõ»¨ 2026-04-02 9/450 2026-04-05 09:27 by cql1109
[¿¼ÑÐ] 295Çóµ÷¼Á +8 xndjjj 2026-04-04 8/400 2026-04-05 08:58 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] 081700£¬311£¬Çóµ÷¼Á +12 ¶¬Ê®Èý 2026-04-04 13/650 2026-04-05 08:43 by qlm5820
[¿¼ÑÐ] ²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á +13 ²×º£ÇáÖÛe 2026-04-04 13/650 2026-04-05 08:27 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 313Çóµ÷¼Á +3 º£ÈÕº£ÈÕ 2026-04-04 5/250 2026-04-05 07:54 by 544594351
[¿¼ÑÐ] 320Çóµ÷¼Á +3 Ò»ÑùÔ² 2026-04-04 3/150 2026-04-04 22:29 by à£à£à£0119
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-02 13/650 2026-04-04 20:49 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µ÷¼Á +4 ÊÇ¿ÉÀÖ²»ÊÇ¿ÉÀÖ 2026-04-04 4/200 2026-04-04 19:41 by ÌÆãå¶ù
[¿¼ÑÐ] 317·Ö Ò»Ö¾Ô¸½­ÄÏ´óѧ »¯Ñ§¹¤³Ìѧ˶ Çóµ÷¼Á +6 YinTai 2026-04-03 6/300 2026-04-03 22:30 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 350Ò»Ö¾Ô¸±±¾©º½¿Õº½Ìì´óѧ08500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +5 kjnasfss 2026-04-03 5/250 2026-04-03 22:29 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©½»Í¨´óѧ²ÄÁϹ¤³Ì×Ü·Ö358 +4 cs0106 2026-04-03 4/200 2026-04-03 13:41 by °ÙÁéͯ888
[¿¼ÑÐ] 282Çóµ÷¼Á +5 ºôÎü¶¼ÊǼõ·Ê 2026-03-31 5/250 2026-04-03 12:03 by 1753564080
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 085602»¯¹¤Çóµ÷¼Á£¨331·Ö£© +9 111@127 2026-03-30 9/450 2026-04-02 20:00 by dick_runner
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò© ³õÊÔ274Çóµ÷¼Á +5 С¶£µ±À´ÁË 2026-03-30 6/300 2026-04-01 14:25 by mxj1203
[¿¼ÑÐ] ¡¾µ÷¼Á¡¿Ò»Ö¾Ô¸ÏôóÉúÎïÓëÒ½Ò©µ÷¼Á +3 EchoϺÃ× 2026-03-31 3/150 2026-04-01 08:40 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼Á +8 11ggg 2026-03-30 8/400 2026-03-31 13:56 by nanaliuyun
[¿¼²©] ²ÄÁÏרҵÉ격 +5 ¶ÅÓêæÃdyt 2026-03-29 5/250 2026-03-31 11:19 by oooqiao
[¿¼ÑÐ] 279Çóµ÷¼Á +12 jµÄÁ¢·½ 2026-03-29 12/600 2026-03-30 20:30 by dick_runner
[¿¼ÑÐ] 296Çóµ÷¼Á +10 ±Ë°¶t 2026-03-29 10/500 2026-03-30 10:50 by ̽123
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û